US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 6.750
- -0.030-0.44%
Close Dec 13 16:00 ET
- 6.710
- -0.040-0.59%
Post 18:50 ET
49.25MMarket Cap-0.51P/E (TTM)
6.960High6.720Low28.72KVolume6.790Open6.780Pre Close195.91KTurnover0.63%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.37P/B30.67MFloat Cap5.20252wk Low--Dividend TTM4.54MShs Float363.268Historical High--Div YieldTTM3.54%Amplitude5.200Historical Low6.821Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Kezar Life Sciences Stock Forum
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet